Amarin Corporation plc (ADR) - AMRN - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 12, 2013

Amarin Corporation plc (ADR) - SIC # 2834

Ticker	Exchange	SIC #	Website	Latest Ticker
AMRN	Nasdaq	2834	http://www.amarincorp.com/	7.14 -0.09
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Amarin Corporation plc (ADR) AMARIN CORP PLC\UK Financials - May 17th, 2013 11:04 am A Disconnect Between Future Prospects of Drug Candidates Versus Where Share Price is Currently Trading: Portfolio Manager Finny Kuruvilla Discusses the Biotech and Pharmaceutical Sectors - May 16th, 2013 1:25 pm Amarin & Celsion: Post-Earnings Roundup - May 15th, 2013 7:54 am Amarin Reports Solid Vascepa TRx Growth, Stock Holds Its Ground - May 13th, 2013 4:33 pm Weekly Stock Watch - Week Of May 13, 2013 - May 11th, 2013 9:06 pm 5 Stocks To Watch For Gains Next Week - May 11th, 2013 8:52 pm Some Fish Oil Doesn't Help Some Patients in Some Countries - May 11th, 2013 9:00 am No Fat in This Drug Launch - May 10th, 2013 12:21 pm Analysts: Nvidia’s Stock Gains are Unjustified and 2 Other Research Notes to Browse - May 10th, 2013 11:10 am Biotech Stock Mailbag: Synta, Zogenix, Sarepta, Amarin - May 10th, 2013 5:00 am Risky Amarin Sets Its Cash Pile On Fire - May 9th, 2013 6:23 pm Amarin Corporation CEO Discusses Q1 2013 Results - Earnings Call Transcript - May 9th, 2013 5:28 pm Amarin Reports First Quarter 2013 Financial Results and Provides Update on Operations - May 9th, 2013 2:05 pm Amarin, Omthera drop following fatty acids study in journal - May 9th, 2013 11:15 am Another Negative Fish Oil Study Adds To Amarin's Marketing Challenges - May 9th, 2013 10:30 am AMARIN CORP PLC\UK Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi - May 9th, 2013 7:09 am Q1 2013 Amarin Corporation PLC Earnings Release - Time Not Supplied - May 9th, 2013 5:07 am Amarin Trouble Grows As Does Evidence Against Fish Oil's Benefits - May 8th, 2013 10:15 pm Another Disappointing Study For Fish Oil Supplements - May 8th, 2013 3:00 pm Top Small-Cap Biotech Stocks Being Accumulated By Large Fund Managers - May 7th, 2013 1:38 pm View All Current Headlines >>